JP Morgan Chase’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6K Sell
586
-20
-3% -$544 ﹤0.01% 6660
2025
Q4
$17.7K Hold
606
﹤0.01% 6537
2025
Q3
$19.4K Sell
606
-1
-0.2% -$32 ﹤0.01% 6483
2025
Q2
$19.9K Hold
607
﹤0.01% 6175
2025
Q1
$17.2K Buy
607
+34
+6% +$1.07K ﹤0.01% 6194
2024
Q4
$16.9K Hold
573
﹤0.01% 6286
2024
Q3
$17.2K Hold
573
﹤0.01% 6265
2024
Q2
$15.1K Hold
573
﹤0.01% 6192
2024
Q1
$16.4K Hold
573
﹤0.01% 6265
2023
Q4
$17.4K Hold
573
﹤0.01% 6281
2023
Q3
$15.8K Hold
573
﹤0.01% 6131
2023
Q2
$20K Sell
573
-520
-48% -$18.1K ﹤0.01% 5915
2023
Q1
$38.4K Buy
1,093
+253
+30% +$9.09K ﹤0.01% 5804
2022
Q4
$29K Buy
840
+267
+47% +$9.39K ﹤0.01% 5771
2022
Q3
$19K Hold
573
﹤0.01% 5826
2022
Q2
$20K Hold
573
﹤0.01% 5898
2022
Q1
$25K Buy
+573
New +$24.8K ﹤0.01% 6027

Other funds holding HEAL

JP Morgan Chase's HEAL Position: Q1 2026 in Review

JP Morgan Chase reduced its Global X Funds Global X HealthTech ETF (HEAL) stake by 3.3% in Q1 2026, selling an estimated $544 and leaving 586 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6660.

JP Morgan Chase first reported a position in HEAL in Q1 2022 and has held it in 17 quarters since. The position peaked at $38.4K in Q1 2023. 30 funds tracked by Wall St. Rank hold HEAL as of Q1 2026.

  • JP Morgan Chase held 586 shares of Global X Funds Global X HealthTech ETF worth $13.6K as of Q1 2026.
  • JP Morgan Chase sold 20 Global X Funds Global X HealthTech ETF shares in Q1 2026, an estimated $544.
  • Global X Funds Global X HealthTech ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6660 holding.
  • JP Morgan Chase first reported a position in Global X Funds Global X HealthTech ETF in Q1 2022 and has held it in 17 quarters since.
  • JP Morgan Chase's Global X Funds Global X HealthTech ETF position peaked at $38.4K in Q1 2023.
  • 30 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.